False Treatment Claims Still A COVID-19 Symptom: FTC Files Complaint Against California Firm
Executive Summary
FTC files complaint alleging Precision Patient Outcomes marketed a supplement as a treatment to mitigate the effects of COVID-19 after agency let the firm know it considered the claims false advertising.
You may also be interested in...
The FTC Complaint Is Fully Visible. The COVID-19 'Mask' Is Not.
New York business partners continued false advertising for “The 1 Virus Buster Card,” to be worn around the neck or clipped onto clothing, on their website and social media platforms after receiving a warning from the US FTC in July 2020.
FTC Complaint Fully Visible Unlike COVID-19 'Mask'
New York business partners continued false advertising for “The 1 Virus Buster Card,” to be worn around the neck or clipped onto clothing, on their website and social media platforms after receiving a warning from in July 2020.
US FTC Section 13(b) Revamp Gains Traction With Senate ‘Fix’ In The Works
There is strong support for a bipartisan fix to discourage marketplace fraud and anticompetitive practices and enable consumer redress under the FTC Act. But Congress is distracted and deeply divided with different ideas about how extensive the FTC’s authorities should be under Section 13(b) of the FTC Act.